Cargando…

The Role of Modeling and Simulation in Development and Registration of Medicinal Products: Output From the EFPIA/EMA Modeling and Simulation Workshop

The European Medicines Agency (EMA) and the Federation of Pharmaceutical Industries and Associations (EFPIA) hosted a workshop on modeling and simulation (M&S).(1) Representatives from industry, academia, and regulatory agencies from Europe and beyond discussed the role of M&S in the develop...

Descripción completa

Detalles Bibliográficos
Autores principales:	Manolis, E, Rohou, S, Hemmings, R, Salmonson, T, Karlsson, M, Milligan, P A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2013
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3600760/ https://www.ncbi.nlm.nih.gov/pubmed/23835942 http://dx.doi.org/10.1038/psp.2013.7

Ejemplares similares

Advanced Methods for Dose and Regimen Finding During Drug Development: Summary of the EMA/EFPIA Workshop on Dose Finding (London 4–5 December 2014)
por: Musuamba, FT, et al.
Publicado: (2017)

Report from the EMA workshop on qualification and reporting of physiologically based pharmacokinetic (PBPK) modeling and simulation
por: Zhao, P
Publicado: (2017)

Modeling and Simulation to Optimize the Design and Analysis of Confirmatory Trials, Characterize Risk–Benefit, and Support Label Claims
por: Marshall, S F, et al.
Publicado: (2013)

Physiologically Based Models in Regulatory Submissions: Output From the ABPI/MHRA Forum on Physiologically Based Modeling and Simulation
por: Shepard, T, et al.
Publicado: (2015)

Non-vitamin-K oral anticoagulants and laboratory testing: now and in the future: Views from a workshop at the European Medicines Agency (EMA)
por: Salmonson, Tomas, et al.
Publicado: (2017)

Modeling and Simulation at the Interface of Nonclinical and Early Clinical Drug Development
por: Visser, S A G, et al.
Publicado: (2013)

Mechanistic Oral Absorption Modeling and Simulation for Formulation Development and Bioequivalence Evaluation: Report of an FDA Public Workshop
por: Zhang, X, et al.
Publicado: (2017)

Model Description Language (MDL): A Standard for Modeling and Simulation
por: Smith, Mike K., et al.
Publicado: (2017)

Open Systems Pharmacology Community—An Open Access, Open Source, Open Science Approach to Modeling and Simulation in Pharmaceutical Sciences
por: Lippert, Jörg, et al.
Publicado: (2019)

Effective Pharmacovigilance System Development: EFPIA-IPVG Consensus Recommendations
por: Peters, Tanja, et al.
Publicado: (2020)

Computational Simulator Models and Invasive Hemodynamic Monitoring as Tools for Precision Medicine in Pulmonary Arterial Hypertension
por: Manzi, Giovanna, et al.
Publicado: (2021)

EFPIA Guideline on a Quality Framework of Principles in Lifelong Learning in Healthcare
por: Hofstädter-Thalmann, Eva, et al.
Publicado: (2022)

Modeling and Simulation in Clinical Pharmacology and Dose Finding
por: Staab, A, et al.
Publicado: (2013)

EMA401: an old antagonist of the AT2R for a new indication in neuropathic pain
por: Keppel Hesselink, Jan M, et al.
Publicado: (2017)

Overview of the Side-Effects of FDA- and/or EMA-Approved Targeted Therapies for the Treatment of Hematological Malignancies
por: Constantinescu, Catalin, et al.
Publicado: (2020)

Quantitative Modeling and Simulation in PMDA: A Japanese Regulatory Perspective
por: Sato, M, et al.
Publicado: (2017)

Simulation as a high stakes assessment tool in emergency medicine
por: O'Leary, Fenton
Publicado: (2015)

The Standard Output: A Tool‐Agnostic Modeling Storage Format
por: Terranova, Nadia, et al.
Publicado: (2018)

Regulating for Bias in Medical Education – Reaction to the Pharmaceutical Industry Updated EFPIA Code of Practice
por: Rodzinka, Marcin, et al.
Publicado: (2019)

A Curriculum Using Simulation Models to Teach Gynecology and Obstetrics to Trainees
por: Ren, He-Ya, et al.
Publicado: (2017)

Using mechanistic models to support development of complex generic drug products: European Medicines Agency perspective
por: Manolis, Efthymios, et al.
Publicado: (2023)

Systems Biology for Simulating Patient Physiology During the Postgenomic Era of Medicine
por: Schmidt, B J
Publicado: (2014)

Modeling and Simulation as a Tool to Bridge Efficacy and Safety Data in Special Populations
por: Harnisch, L, et al.
Publicado: (2013)

Pembrolizumab: Role of Modeling and Simulation in Bringing a Novel Immunotherapy to Patients With Melanoma
por: de Greef, R, et al.
Publicado: (2016)

EMA issues recommendations on impurities in medicines
Publicado: (2020)

EMA Review of Daratumumab for the Treatment of Adult Patients with Multiple Myeloma
por: Tzogani, Kyriaki, et al.
Publicado: (2018)

Integrative biological simulation praxis: Considerations from physics, philosophy, and data/model curation practices
por: Sarma, Gopal P., et al.
Publicado: (2017)

Molecular Modeling and Simulation Tools in the Development of Peptide-Based Biosensors for Mycotoxin Detection: Example of Ochratoxin
por: Thyparambil, Aby A., et al.
Publicado: (2017)

Activity and perspective on quantitative modeling and simulation in Japan: Update from the Pharmaceuticals and Medical Devices Agency
por: Kijima, Shinichi, et al.
Publicado: (2022)

Dynamic Regulatory Assessment: evolving the European Regulatory Framework for the Benefit of Patients and Public Health—an EFPIA View
por: Herrero-Martinez, Esteban, et al.
Publicado: (2022)

Development of best practices in physiologically based pharmacokinetic modeling to support clinical pharmacology regulatory decision‐making—A workshop summary
por: Jean, Daphney, et al.
Publicado: (2021)

Simulation for training in resource-restricted countries: using a scalable temporal bone surgical simulator
por: Wiet, Gregory J., et al.
Publicado: (2016)

Model Informed Drug Development: Collaboration Through A Common Framework
por: Anziano, Richard J., et al.
Publicado: (2020)

EMA Review of Panobinostat (Farydak) for the Treatment of Adult Patients with Relapsed and/or Refractory Multiple Myeloma
por: Tzogani, Kyriaki, et al.
Publicado: (2018)

EMA Review of Panobinostat (Farydak) for the Treatment of Adult Patients with Relapsed and/or Refractory Multiple Myeloma
por: Tzogani, Kyriaki, et al.
Publicado: (2017)

Nonclinical Studies that Support Viral Vector-Delivered Gene Therapies: An EFPIA Gene Therapy Working Group Perspective
por: Bolt, Michael W., et al.
Publicado: (2020)

Simulation-a new educational paradigm?
por: Konia, Mojca, et al.
Publicado: (2013)

Shape Dependent EMA Model of Nanostructured Anisotropic Materials
por: Otipka, Petr, et al.
Publicado: (2019)

Civil registration and vital statistics in health systems
por: Jackson, Debra, et al.
Publicado: (2018)

Engineering microbial consortia for controllable outputs
por: Lindemann, Stephen R, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_m6bv9gn6ha21f6umkm4n070o6o